Zobrazeno 1 - 10
of 992
pro vyhledávání: '"Joel Moss"'
Autor:
Atsushi Kasamatsu, Ryunosuke Nozaki, Kohei Kawasaki, Tomoaki Saito, Chikashi Minemura, Naohiko Seki, Joel Moss, Katsuhiro Uzawa
Publikováno v:
Cancers, Vol 16, Iss 6, p 1242 (2024)
microRNAs (miRs) function in cancer progression as post-transcriptional regulators. We previously reported that endogenous circular RNAs (circRNAs) function as efficient miR sponges and could act as novel gene regulators in oral squamous cell carcino
Externí odkaz:
https://doaj.org/article/eb95d0147a0e4c96b7fbdeca5ecea59f
Publikováno v:
ERJ Open Research, Vol 9, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/0569d780e8144789a3b780aaebb3607f
Autor:
Angelo M. Taveira-DaSilva, Vissaagan Gopalakrishnan, Jianhua Yao, Marcus Y. Chen, Patricia Julien-Williams, Amanda M. Jones, Gustavo Pacheco-Rodriguez, Joel Moss
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Objectives Lymphangioleiomyomatosis (LAM) patients with severe lung disease may be considered for lung transplantation. Clinical, physiologic, and quality of life data are usually employed for referral. The aim of this study was to determine
Externí odkaz:
https://doaj.org/article/60b5f634a12f4adeb77489c9b6463535
Autor:
Alison M. Treichel, Barbara Boeszoermenyi, Chyi-Chia Richard Lee, Joel Moss, David J. Kwiatkowski, Thomas N. Darling
Publikováno v:
JID Innovations, Vol 3, Iss 2, Pp 100180- (2023)
Skin findings can be critical to determining whether a patient with lymphangioleiomyomatosis (LAM), a progressive pulmonary disease that predominantly affects adult women, has sporadic LAM or LAM in association with tuberous sclerosis complex (TSC).
Externí odkaz:
https://doaj.org/article/f69759275c934319968b6742b90a03cb
Publikováno v:
Bioengineering, Vol 10, Iss 11, p 1255 (2023)
(1) Background: Lymphangioleiomyomatosis is a genetic disease that affects mostly women of childbearing age. In the lungs, it manifests as the progressive formation of air-filled cysts and is associated with a decline in lung function. With a median
Externí odkaz:
https://doaj.org/article/8f193626bbd1451eb35936c9c34c7eee
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-11 (2021)
Abstract Locus for Enterocyte Effacement (LEE)-positive Shiga-toxigenic Escherichia coli (STEC) contributes to many global foodborne diseases, with infection characterized by severe gastrointestinal symptoms, including bloody diarrhea. The incidence
Externí odkaz:
https://doaj.org/article/c2e2c7f6840245439c4e19b51fc61a57
Autor:
Julie Ng, Gustavo Pacheco-Rodriguez, Lesa Begley, Yvonne J. Huang, Sergio Poli, Mark A. Perrella, Ivan O. Rosas, Joel Moss, Souheil El-Chemaly
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-5 (2021)
Abstract Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease with mortality driven primarily by respiratory failure. Patients with LAM frequently have respiratory infections, suggestive of a dysregulated microbiome. Here we demonstrat
Externí odkaz:
https://doaj.org/article/2859b588f641479e8cd8d634b2795490
Autor:
Katarzyna Klonowska, Joannes M. Grevelink, Krinio Giannikou, Barbara A. Ogorek, Zachary T. Herbert, Aaron R. Thorner, Thomas N. Darling, Joel Moss, David J. Kwiatkowski
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 10 (2022)
Background Tuberous sclerosis complex (TSC) is a neurogenetic syndrome due to loss-of-function mutations in TSC2 or TSC1, characterized by tumors at multiple body sites, including facial angiofibroma (FAF). Here, an ultrasensitive assessment of the e
Externí odkaz:
https://doaj.org/article/702bdb854df14b3fa35510627c3d82e1
Autor:
Hiroko Ishiwata-Endo, Jiro Kato, Sachiko Yamashita, Chanbora Chea, Kazushige Koike, Duck-Yeon Lee, Joel Moss
Publikováno v:
Cells, Vol 11, Iss 23, p 3853 (2022)
The ARH family of ADP-ribose-acceptor hydrolases consists of three 39-kDa members (ARH1-3), with similarities in amino acid sequence. ARH1 was identified based on its ability to cleave ADP-ribosyl-arginine synthesized by cholera toxin. Mammalian ADP-
Externí odkaz:
https://doaj.org/article/cf809d604511402aa66bc4e2a37fbf11
Autor:
Ancy Thomas, Saurav Sumughan, Emilia R. Dellacecca, Rohan S. Shivde, Nicola Lancki, Zhussipbek Mukhatayev, Cristina C. Vaca, Fei Han, Levi Barse, Steven W. Henning, Jesus Zamora-Pineda, Suhail Akhtar, Nikhilesh Gupta, Jasmine O. Zahid, Stephanie R. Zack, Prathyaya Ramesh, Dinesh Jaishankar, Agnes S.Y. Lo, Joel Moss, Maria M. Picken, Thomas N. Darling, Denise M. Scholtens, Daniel F. Dilling, Richard P. Junghans, I. Caroline Le Poole
Publikováno v:
JCI Insight, Vol 6, Iss 22 (2021)
Mutations underlying disease in tuberous sclerosis complex (TSC) give rise to tumors with biallelic mutations in TSC1 or TSC2 and hyperactive mammalian target of rapamycin complex 1 (mTORC1). Benign tumors might exhibit de novo expression of immunoge
Externí odkaz:
https://doaj.org/article/f0d788c1bbd34b7ead95bd619eb9df37